Leucovorin Calcium Injection Recalled Due to Sterility Concerns
Teva Pharmaceuticals is recalling Leucovorin Calcium for Injection (350 mg/vial) distributed nationwide because the manufacturer cannot assure the product meets sterility standards.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a parenteral (injectable) pharmaceutical product. Loss of sterility assurance in injectable medications poses serious risk of infection and potential hospitalization, meeting the Severe classification criterion.
Plain-English summary
Teva Pharmaceuticals USA is recalling Leucovorin Calcium for Injection, USP 350 mg/vial in 17.5 mL single-use vials. The recall affects approximately 434,229 vials that were distributed nationwide, including Puerto Rico. The recall is due to a lack of assurance of sterility.
The affected lot numbers are: 31325852B, 31325985B (exp. 10/2021); 31326349B (exp. 01/2022); 31326873B (exp. 03/2022); 31326995B (exp. 05/2022); 31327158B (exp. 06/2022); and 31328946B and 31329180B (exp. 05/2023). The product is distributed under the manufacturer Teva Parenteral Medicines, Inc., Irvine, CA 92618.
Patients and healthcare providers in possession of affected lots should consult with a healthcare professional regarding appropriate next steps. The product is prescription-only and is identified by NDC 0703-5145-01.
The recalled product
- Product
- Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618, NDC 0703-5145-01
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Injectable / Parenteral
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Lot #: 31325852B
- 31325985B
- exp. date 10/2021
- 31326349B
- exp. date 01/2022
- 31326873B
- exp. date 03/2022
- 31326995B
- exp. date 05/2022 31327158B
- exp. date 06/2022
- 31328946B
- 31329180B
- exp. date 05/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27